Results for tag: "Darolutamide"

Darolutamide is a novel androgen receptor inhibitor used in the treatment of prostate cancer. It is a non-steroidal anti-androgen that works by blocking the action of androgens, such as testosterone, in the body. Darolutamide is used in combination with other drugs to treat advanced prostate cancer that has spread to other parts of the body. It is also used to delay the progression of the disease in men who have not yet received chemotherapy. Darolutamide is taken orally, usually twice a day. Darolutamide is a relatively new drug in the prostate cancer market, but it has been gaining traction due to its efficacy and safety profile. It has been shown to be well tolerated and to have fewer side effects than other drugs used to treat prostate cancer. Some companies in the Darolutamide market include Bayer, Astellas Pharma, and Orion Corporation. Show Less Read more